University of Arkansas-School of Medical Sciences First Hospital in Arkansas Approved to Provide Breakthrough CAR T-Cell Therapy for Non-Hodgkin Lymphoma
September 21, 2019
September 21, 2019
LITTLE ROCK, Arkansas, Sept. 21 [TNSmedicalresearch] -- The University of Arkansas's School of Medical Sciences issued the following news release:
The University of Arkansas for Medical Sciences (UAMS) is the first and only hospital in Arkansas approved to provide a revolutionary new therapy for certain types of non-Hodgkin lymphoma.
Chimeric antigen receptor (CAR) T-cell therapy uses new technology to genetically modify a patient's own T cells, enabling them to seek an . . .
The University of Arkansas for Medical Sciences (UAMS) is the first and only hospital in Arkansas approved to provide a revolutionary new therapy for certain types of non-Hodgkin lymphoma.
Chimeric antigen receptor (CAR) T-cell therapy uses new technology to genetically modify a patient's own T cells, enabling them to seek an . . .